Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Progyny Community
NasdaqGS:PGNY Community
3
Narratives
written by author
0
Comments
on narratives written by author
40
Fair Values set
on narratives written by author
Community Investing Ideas
Progyny
Popular
Undervalued
Overvalued
Progyny
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Tightening US Healthcare Policies And Gig Shifts Will Dampen Prospects
Key Takeaways Policy shifts and workforce trends threaten to shrink Progyny's eligible customer base and dampen long-term growth prospects. Intensifying competition, regulatory scrutiny, and disruptive technologies pose risks to profitability, client retention, and future demand for services.
View narrative
US$21.00
FV
3.6% overvalued
intrinsic discount
8.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Progyny
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Investments In BenefitBump And Digital Assets Will Improve Service Offerings And Member Engagement
Key Takeaways New partnerships and recent acquisitions are expected to drive revenue growth by expanding service access and enhancing offerings. Continued investment in digital assets and diverse product expansion could increase utilization and revenue per client, supporting growth despite potential client losses.
View narrative
US$26.75
FV
18.7% undervalued
intrinsic discount
9.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
5 days ago
author updated this narrative
Progyny
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Rising Maternal Age And Digital Health Will Expand Markets
Key Takeaways Rising demand for comprehensive fertility and women’s health benefits, coupled with employer adoption, fuels sustained client growth and higher long-term revenue potential. Diversification into maternity, menopause, and strategic partnerships enhances cross-sell opportunities, margin expansion, and positions the company for broader women’s health market leadership.
View narrative
US$33.59
FV
35.2% undervalued
intrinsic discount
11.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 months ago
author updated this narrative
Your Valuation for
PGNY
PGNY
Progyny
Your Fair Value
US$
Current Price
US$21.75
27.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-10m
2b
2015
2018
2021
2024
2025
2027
2030
Revenue US$1.9b
Earnings US$79.6m
Advanced
Set Fair Value